Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|September 15, 2011
[Characteristics of ertapenem use in critical state patients]V B BeloborodovTerapevticheskii Arkhiv|October 26, 2022
[The role and place of pathogenetic therapy with glucocorticosteroid hormones in the treatment of patients with novel coronavirus infection (COVID-19)]D O Efremov, V B BeloborodovAntibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|September 15, 2011
[Actual aspects of sepsis]K P Gruver, V B Beloborodov, T N Kuz'menkoMedicine|November 1, 1993
Meningococcal disease in patients with late complement component deficiency: studies in the U.S.S.RA E Platonov, V B Beloborodov, I V VershininaAnesteziologiia I Reanimatologiia|March 1, 1990
[Hemodynamics and rheologic properties of the blood in meningococcemia associated with meningitis and complicated by septic shock and intracranial hypertension]G G Radzivil, V B Beloborodov, Iu V BronikinTerapevticheskii Arkhiv|January 8, 2000
[Clinical features of meningococcal infection in subjects with deficient terminal components of complement]A E Platonov, V B Beloborodov, I V VershininaSovetskaia Meditsina|January 1, 1990
[Characteristics of blood circulation disorders in meningococcal meningoencephalitis]G G Radzivil, V B Beloborodov, I M Roslyĭ, et al.Clinical and Experimental Immunology|April 1, 1995
Vaccination of patients deficient in a late complement component with tetravalent meningococcal capsular polysaccharide vaccineA E Platonov, V B Beloborodov, L I Pavlova, et al.Klinicheskaia Meditsina|June 25, 1999
[The interconnection between the severity of meningococcal infection and the endotoxicity levels and patient's blood complement]A E Platonov, D V Troshchanskiĭ, V B Beloborodov, et al.Clinical Immunology and Immunopathology|August 1, 1992
Immunological evaluation of late complement component-deficient individualsA E Platonov, V B Beloborodov, D I Gabrilovitch, et al.Pageof 2